UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------
OMB APPROVAL
---------------------------------
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response.............11
SCHEDULE 13D
Under the Securities and Exchange Act of 1934
(Amendment No. 3 )*
DIACRIN, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
25243N103
--------------------------------------------------------------------------------
(CUSIP Number)
Jeffrey B. Steinberg
HealthCare Ventures LLC
44 Nassau Street
Princeton, New Jersey 08542
(609) 430-3900
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
August 21, 2003
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original
and five copies of the schedule, including all exhibits. See Rule 13d-7 for
other parties to whom copies are to be sent.
----------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 25243N103 13D Page 1 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Ventures II, L.P.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 2 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Partners II, L.P.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 3 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Ventures III, L.P.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 4 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Partners III, L.P.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES
_________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 5 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Ventures IV, L.P.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 6 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Partners IV, L.P.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 7 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
James H. Cavanaugh, Ph.D.
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 8 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Harold R. Werner
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 9 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
William Crouse
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 10 of 11 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
John W. Littlechild
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
N/A
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 0
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 0
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 0
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0%
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 25243N103 13D Page 11 of 11 Pages
________________________________________________________________________________
Item 1. Security and Issuer.
This statement relates to the common stock, $.01 par value
each ("Common Stock") of Diacrin, Inc. (the "Issuer"). The address of
the Issuer's principal executive office is Building 96, 13th Street,
Charlestown, MA 02120.
________________________________________________________________________________
Item 2. Identity and Background.
(a) The name of the reporting persons are HealthCare Ventures
II, L.P. ("HCVII"), HealthCare Partners II, L.P. ("HCPII"), HealthCare
Ventures III, L.P. ("HCVIII"), HealthCare Partners III, L.P.
("HCPIII"), HealthCare Ventures IV, L.P. ("HCVIV"), HealthCare Partners
IV, L.P. ("HCPIV"), Dr. Cavanaugh and Messrs. Werner, Crouse, and
Littlechild (HCVII, HCPII, HCVIII, HCPIII, HCVIV, HCPIV, Dr. Cavanaugh
and Messrs. Werner, Crouse and Littlechild are hereafter sometimes
hereinafter referred to as the "Reporting Persons"). A copy of their
agreement in writing to file this statement on behalf of each of them
is attached hereto as Exhibit A. HCVII, HCPII, HCVIII and HCPIII, HCVIV
and HCPIV are limited partnerships organized and existing under the
laws of the State of Delaware. HCPII is the General Partner of HCVII,
HCPIII is the General Partner of HCVIII and HCPIV is the General
Partner of HCVIV. Dr. Cavanaugh and Messrs.Werner, Crouse and
Littlechild are the general partners of HCPII, HCPIII and HCPIV.
(b) The business address for HCVII, HCPII, HCVIII, HCPIII,
HCVIV and HCPIV, Dr. Cavanaugh and, Messrs. Werner and Crouse is 44
Nassau Street, Princeton, New Jersey 08542. The business address for
Mr. Littlechild is One Kendall Square, Building 300, Cambridge,
Massachusetts 02339.
(c) Each of Dr. Cavanaugh and Messrs. Werner, Crouse and
Littlechild are general partners of various venture capital investment
funds. The address for Dr. Cavanaugh and Messrs. Werner and Crouse is
44 Nassau Street, Princeton, New Jersey 08542 and the address for Mr.
Littlechild is One Kendall square, Building 300, Cambridge, MA 02339.
(d) Not Applicable.
________________________________
1 Dr. Cavanaugh and Messrs Werner, Littlechild and Crouse are the general
partners of HCPII, HCPIII and HCPIV, the General Partners of HCVII,
HCVIII and HCVIV, the record holders of the Issuer's securities.
(e) Not Applicable.
(f) Dr. Cavanaugh and Messrs. Werner, Crouse and Littlechild
are each individuals who are citizens of the United States.
________________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
Not Applicable
________________________________________________________________________________
Item 4. Purpose of Transaction.
(a) Not Applicable.
(b) On August 22, 2003, the Issuer and GenVec, Inc.
("GenVec")consummated a merger pursuant to which the Issuer merged with
and into GenVec (the "Merger"). In connection with the terms of the
Merger, each share of the Issuer's Common Stock was exchanged for
1.5292 shares of GenVec's common stock in a tax-free transaction. On
August 22, 2003, the Issuer ceased to have independent existence as a
reporting person under the Securities and Exchange Act of 1934 and the
Reporting Persons no longer own any shares of Common Stock of the
Issuer.
(c) Not Applicable.
(d) Not Applicable.
(e) Not Applicable.
(f) Not Applicable.
(g) Not Applicable.
(h) Not Applicable.
(i) Not Applicable.
(j) Not Applicable.
________________________________________________________________________________
Item 5. Interest in Securities of the Issuer.
(a) The Reporting Persons do not own any shares of the Common Stock of
the Issuer. (b) Not Applicable. (c) On August 22, 2003, the 3,196,385 shares of
Common Stock of the Issuer owned by HCVII were converted into 4,887,912 shares
of Common Stock of GenVec. On August 22, 2003, the 994,078 shares of Common
Stock of the Issuer owned by HCVIII were converted into 1,520,144 shares of the
Common Stock of GenVec. On August 22, 2003, the 291,922 shares of Common Stock
of the Issuer owned by HCVIV were converted into 446,407 shares of Common Stock
of GenVec.
(d) Not Applicable.
(e) The Reporting Persons ceased to be the beneficial owner of more
than five percent of the class of securities on August 22, 2003.
________________________________________________________________________________
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
Not Applicable.
________________________________________________________________________________
Item 7. Material to be Filed as Exhibits.
Exhibit A - Joint Filing Agreement.
________________________________________________________________________________
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: August 21, 2003 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner,
HealthCare Partners II, L.P.
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Partners II, L.P.
Princeton, New Jersey
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Ventures III, L.P.,
Princeton, New Jersey by its General Partner,
HealthCare Partners III, L.P.
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Partners III, L.P.
Princeton, New Jersey
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Ventures IV, L.P.,
Princeton, New Jersey by its General Partner,
HealthCare Partners IV, L.P.
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Partners IV, L.P.
Princeton, New Jersey
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey -------------------------------------------
James H. Cavanaugh, Ph.D.
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey -------------------------------------------
Harold R. Werner
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey -------------------------------------------
William Crouse
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts -------------------------------------------
John W. Littlechild
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13D
The undersigned hereby consent to the joint filing by any of them of a
Statement on Schedule 13D and any amendments thereto, whether heretofore or
hereafter filed, relating to the securities of Diacrin, Inc., and affirm that
this Schedule 13D is being filed on behalf of each of the undersigned.
Dated: August 21, 2003 HealthCare Ventures II, L.P.,
Princeton, New Jersey by its General Partner,
HealthCare Partners II, L.P.
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Partners II, L.P.
Princeton, New Jersey
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Ventures III, L.P.,
Princeton, New Jersey by its General Partner,
HealthCare Partners III, L.P.
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Partners III, L.P.
Princeton, New Jersey
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Ventures IV, L.P.,
Princeton, New Jersey by its General Partner,
HealthCare Partners IV, L.P.
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 HealthCare Partners IV, L.P.
Princeton, New Jersey
By: S/Jeffrey Steinberg, Administrative Partner
-------------------------------------------
Administrative Partner
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey -------------------------------------------
James H. Cavanaugh, Ph.D.
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey -------------------------------------------
Harold R. Werner
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey -------------------------------------------
William Crouse
Dated: August 21, 2003 By: S/Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts -------------------------------------------
John W. Littlechild
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).